BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387
140542 results:

  • 1. ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2).
    Ghosal N; Tapadar P; Biswas D; Pal R
    Mol Biol Rep; 2024 May; 51(1):671. PubMed ID: 38787503
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
    Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
    Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modulation of heat shock protein expression and cytokine levels in MCF-7 cells through photodynamic therapy.
    Dos Santos MIB; Godoi BH; Da Silva NS; Oliveira LD; de Paula Ramos L; Cintra RC; Pacheco-Soares C
    Lasers Med Sci; 2024 May; 39(1):135. PubMed ID: 38787412
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. breast Glandular and Ductal Volume Changes during the Menstrual Cycle: A Study in 48 breasts Using Ultralow-Frequency Transmitted Ultrasound Tomography/Volography.
    Wiskin J; Klock J; Love S
    Tomography; 2024 May; 10(5):789-805. PubMed ID: 38787020
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
    Longo CJ; Maity T; Fitch MI; Young JT
    Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sonographic Evaluation of Nigerian Women with Mammographic Focal Asymmetric Density.
    Itanyi DU; Ibrahim H; Ka'alu WO
    West Afr J Med; 2024 Mar; 41(3):233-237. PubMed ID: 38785292
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
    Chen L; Yan X; Luo T; Tian T; He P; Zhong X
    Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Investigation of calcium variations in single cells and the impact of Yoda1 on osteocytes by ICP-OES.
    Guo X; Lin CY; Alavi S; You L; Mostaghimi J
    Anal Chim Acta; 2023 Nov; 1281():341906. PubMed ID: 38783744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
    Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
    BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]    [Full Text] [Related]  

  • 11. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
    Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
    [No Abstract]    [Full Text] [Related]  

  • 12. A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.
    Bulanova D; Akimov Y; Senkowski W; Oikkonen J; Gall-Mas L; Timonen S; Elmadani M; Hynninen J; Hautaniemi S; Aittokallio T; Wennerberg K
    Sci Adv; 2024 May; 10(21):eadj1564. PubMed ID: 38781347
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study.
    Carson EK; Dhillon HM; Vardy JL; Brown C; Nunes-Zlotkowski KF; Della-Fiorentina S; Khan S; Parsonson A; Roncoloato F; Pearson A; Barnes T; Kiely BE
    Support Care Cancer; 2024 May; 32(6):375. PubMed ID: 38780707
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Noninvasive Assessment of Tumor Histological Grade in Invasive breast Carcinoma Based on Ultrasound Radiomics and Clinical Characteristics: A Multicenter Study.
    Ge L; Wu J; Jin Y; Xu D; Wang Z
    Technol Cancer Res Treat; 2024; 23():15330338241257424. PubMed ID: 38780506
    [No Abstract]    [Full Text] [Related]  

  • 15. Mechanistic evaluation of myristicin on apoptosis and cell cycle regulation in breast cancer cells.
    Sufina Nazar S; Ayyappan JP
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23740. PubMed ID: 38779996
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
    Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
    Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reporting on patient's body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review.
    Van Cauwenberge J; Van Baelen K; Maetens M; Geukens T; Nguyen HL; Nevelsteen I; Smeets A; Deblander A; Neven P; Koolen S; Wildiers H; Punie K; Desmedt C
    Breast Cancer Res; 2024 May; 26(1):81. PubMed ID: 38778365
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.
    Giannubilo I; Battistuzzi L; Blondeaux E; Ruelle T; Poggio FB; Buzzatti G; D'Alonzo A; Della Rovere F; Latocca MM; Molinelli C; Razeti MG; Nardin S; Arecco L; Perachino M; Favero D; Borea R; Pronzato P; Del Mastro L; Bighin C
    BMC Palliat Care; 2024 May; 23(1):129. PubMed ID: 38778303
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Drug screening on digital microfluidics for cancer precision medicine.
    Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
    Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hereditary breast cancer: BRCA Mutations and Beyond.
    Patel MM; Adrada BE
    Radiol Clin North Am; 2024 Jul; 62(4):627-642. PubMed ID: 38777539
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7028.